Jasper Therapeutics, Inc. (JSPR)
NASDAQ: JSPR · Real-Time Price · USD
21.57
+0.04 (0.19%)
Dec 20, 2024, 4:00 PM EST - Market closed
Jasper Therapeutics Stock Forecast
Stock Price Forecast
The 8 analysts with 12-month price forecasts for Jasper Therapeutics stock have an average target of 73.38, with a low estimate of 63 and a high estimate of 90. The average target predicts an increase of 240.19% from the current stock price of 21.57.
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for JSPR stock from 11 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Jul '24 | Aug '24 | Sep '24 | Oct '24 | Nov '24 | Dec '24 |
|---|---|---|---|---|---|---|
| Strong Buy | 3 | 3 | 3 | 3 | 3 | 3 |
| Buy | 7 | 5 | 7 | 7 | 7 | 8 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 10 | 8 | 10 | 10 | 10 | 11 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| BMO Capital | BMO Capital | Buy Initiates $63 | Buy | Initiates | $63 | +192.07% | Dec 6, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $65 | Strong Buy | Reiterates | $65 | +201.34% | Oct 24, 2024 |
| JMP Securities | JMP Securities | Buy Reiterates $70 | Buy | Reiterates | $70 | +224.52% | Oct 15, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $65 | Strong Buy | Reiterates | $65 | +201.34% | Oct 15, 2024 |
| JMP Securities | JMP Securities | Buy Reiterates $70 | Buy | Reiterates | $70 | +224.52% | Sep 27, 2024 |
Financial Forecast
Revenue This Year
n/a
Revenue Next Year
4.99M
EPS This Year
-4.66
from -6.18
EPS Next Year
-4.57
from -4.66
Revenue Forecast
| Revenue | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|---|
| High | n/a | 46.2M | 10.5M | |||
| Avg | n/a | 5.0M | 1.7M | |||
| Low | n/a | n/a | n/a |
Revenue Growth
| Revenue Growth | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|---|
| High | - | - | 110.5% | |||
| Avg | - | - | -66.8% | |||
| Low | - | - | - |
EPS Forecast
| EPS | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|---|
| High | -4.45 | -2.63 | -3.78 | |||
| Avg | -4.66 | -4.57 | -4.90 | |||
| Low | -5.04 | -6.42 | -6.23 |
EPS Growth
| EPS Growth | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|---|
| High | - | - | - | |||
| Avg | - | - | - | |||
| Low | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.